Search Results 581-590 of 7001 for Isotope

1. Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies - Mayo Clinic

   Subjects must not be eligible for therapy of higher curative potential where an alternative treatment has been shown to prolong survival in an analogous ...

2. Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)

   About this study. Hematopoietic cell transplants (HCT) are one treatment option for people with leukemia or lymphoma. Family members, unrelated donors or ...

3. National Biological Sample and Data Repository for Pulmonary Arterial Hypertension - Mayo Clinic

   The purpose of this study is to establish a collection, termed biorepository or biobank, of samples as well as both clinical and genetic data from patients with ...

4. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time - Mayo Clinic

   About this study. The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to ...

5. Longterm Follow-up of Subjects Treated With bb2121 - Mayo Clinic

   bb2121 is administered in subjects 1 time (or retreated if retreatment criteria are met) in parent clinical study. No investigational treatment will be ...

6. A Study To Investigate The Safety And Preliminary Efficacy Of Allo-329, An Immune Cell Therapy, In Adults With Autoimmune Disease - Mayo Clinic

   The purpose of this sudy is to assess the safety of ALLO-329 in participants with autoimmune disease. To establish a recommended Phase 2 regimen (RP2R).

7. Dasatinib And Quercetin With CAR T Therapy For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   Dasatinib is in a class of medications called tyrosine kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to ...

8. Trainee Remediation Trends and Outcome - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...

10. Risk-Adapted Chemotherapy in Younger Patients with Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia - Mayo Clinic

    About this study. This partially randomized phase III clinical trial is studying different combinations of risk-adapted chemotherapy regimens and their side ...